Supplementary File S2 from Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial
收藏数据链接：
官方服务：
资源简介：
Supplementary File S2. Sequencing depth, coverage, and other relevant parameters related to WES screening.
创建时间：
2025-05-01
